Literature DB >> 9614115

The human proteinase-activated receptor-3 (PAR-3) gene. Identification within a Par gene cluster and characterization in vascular endothelial cells and platelets.

V A Schmidt1, W C Nierman, D R Maglott, L D Cupit, K A Moskowitz, J A Wainer, W F Bahou.   

Abstract

Proteolytically activated receptors (PARs) represent an emerging subset of seven transmembrane G protein-coupled receptors that mediate cell activation events by receptor cleavage at distinct scissile bonds located within receptor amino termini. Differential genomic blotting using a yeast artificial chromosome known to contain the PAR-1 and PAR-2 genes identified the PAR-3 gene within a PAR gene cluster spanning approximately 100 kilobases at 5q13. The PAR-3 gene is relatively small (approximately 12 kilobases); and, like the PAR-1 and PAR-2 genes, it displays a two-exon structure, with the majority of the coding sequence and the proteolytic cleavage site contained within the larger second exon. Sequence analysis of the 5'-flanking region demonstrates that the promoter is TATA-less, similar to that seen with PAR-1, with the identification of nucleic acid motifs potentially involved in transcriptional gene regulation, including AP-1, GATA, and octameric sequences. PAR-3 transcripts were apparent in human vascular endothelial cells, although at considerably lower levels than those of PAR-1 and not significantly modulated by the endothelial cell stimulus tumor necrosis factor-alpha. Likewise, although PAR-3 mRNA was evident in human platelets, receptor cell surface expression was modest (approximately 10%) compared with that of PAR-1. Thus, although PAR-3 is postulated to represent a second thrombin receptor, its modest endothelial cell and platelet expression suggest that PAR-3 activation by alpha-thrombin is less relevant for physiological responses in these mature cells. Rather, given its disparately greater expression in megakaryocytes (and megakaryocyte-like human erythroleukemia cells), a regulatory role in cellular development (by protease activation) could be postulated.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9614115     DOI: 10.1074/jbc.273.24.15061

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

Review 1.  How the protease thrombin talks to cells.

Authors:  S R Coughlin
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

2.  Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin.

Authors:  M L Kahn; M Nakanishi-Matsui; M J Shapiro; H Ishihara; S R Coughlin
Journal:  J Clin Invest       Date:  1999-03       Impact factor: 14.808

3.  Arginine-specific protease from Porphyromonas gingivalis activates protease-activated receptors on human oral epithelial cells and induces interleukin-6 secretion.

Authors:  A Lourbakos; J Potempa; J Travis; M R D'Andrea; P Andrade-Gordon; R Santulli; E J Mackie; R N Pike
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

Review 4.  Proteinases and signalling: pathophysiological and therapeutic implications via PARs and more.

Authors:  R Ramachandran; M D Hollenberg
Journal:  Br J Pharmacol       Date:  2007-12-03       Impact factor: 8.739

5.  Mutation-prone points in thrombin receptor.

Authors:  Viroj Wiwanitkit
Journal:  J Thromb Thrombolysis       Date:  2007-12-07       Impact factor: 2.300

6.  Targeting protease-activated receptor-1 with cell-penetrating pepducins in lung cancer.

Authors:  Jaroslaw Cisowski; Katie O'Callaghan; Athan Kuliopulos; John Yang; Nga Nguyen; Qing Deng; Eric Yang; Michael Fogel; Sarah Tressel; Caitlin Foley; Anika Agarwal; Stephen W Hunt; Tom McMurry; Larry Brinckerhoff; Lidija Covic
Journal:  Am J Pathol       Date:  2011-05-07       Impact factor: 4.307

7.  Activation of pro-(matrix metalloproteinase-2) (pro-MMP-2) by thrombin is membrane-type-MMP-dependent in human umbilical vein endothelial cells and generates a distinct 63 kDa active species.

Authors:  M A Lafleur; M D Hollenberg; S J Atkinson; V Knäuper; G Murphy; D R Edwards
Journal:  Biochem J       Date:  2001-07-01       Impact factor: 3.857

8.  Protease-activated receptors in cancer: A systematic review.

Authors:  Na Han; Ketao Jin; Kuifeng He; Jiang Cao; Lisong Teng
Journal:  Oncol Lett       Date:  2011-04-08       Impact factor: 2.967

9.  Receptor tyrosine kinase EphA2 mediates thrombin-induced upregulation of ICAM-1 in endothelial cells in vitro.

Authors:  Barden Chan; Vikas P Sukhatme
Journal:  Thromb Res       Date:  2008-09-03       Impact factor: 3.944

10.  Thrombin receptors and protease-activated receptor-2 in human placentation: receptor activation mediates extravillous trophoblast invasion in vitro.

Authors:  Peter J O'Brien; Hideki Koi; Samuel Parry; Lawrence F Brass; Jerome F Strauss; Li-Peng Wang; John E Tomaszewski; Lane K Christenson
Journal:  Am J Pathol       Date:  2003-10       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.